US Regulatory Process For Genetically Modified Trees
Lara Vallely
Summer 2002

See who's visiting this page.

Overview

In 1986, the White House Office of Science and Technology Policy established the Coordinated Framework for the Regulation of Products of Biotechnology (Coordinated Framework). Through the Coordinated Framework the federal government expressed its commitment to the safe development of genetically modified organisms, and established regulatory authority over products of biotechnology for 3 federal agencies. 1

The foundation of US regulation established in the Coordinated Framework is the underlying assumption that the risks associated with products of biotechnology are no different than risks associated with conventional breeding. Specifically, regulation assumes that introducing a genetically modified organism into an ecosystem holds no more risk than introducing unmodified organisms or organisms modified by conventional breeding techniques. Essentially, the Coordinated Framework established regulation that looked at genetically modified products according to their characteristics and novel features, and not by their method of production. 2

Under the Coordinated Framework, the Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA), the Environmental Protection Agency (EPA), and the Food and Drug Administration (FDA) are responsible for evaluating the safety of genetically modified crops. Products are regulated according to their intended use, leaving some products regulated by more than one agency. The following chart displays the regulatory responsibility of each agency.

Chart1. Overview of U.S. regulatory agencies and their oversight jurisdiction.
Source: USDA Overview of Regulatory Oversight in biotechnology. http://www.aphis.usda.gov/ppq/biotech/usregs.html

AgencyProducts RegulatedRegulated For
APHISPlant pests, plants, veterinary biologics Safe to grow
EPAMicrobial/plant pesticides, new uses of existing pesticides, novel microorganisms Safe for the environment
FDAFood, feed, food additives, veterinary drugs, human drugs and medical devices Safe to eat

Trees genetically modified to enhance timber quality would regularly fall under the regulatory authority of two of these agencies, APHIS and EPA.

USDA�APHIS

APHIS has the large and encompassing responsibility to protect the U.S.�s animal and plant resources. To do this, APHIS has been given specific regulatory authority to �safeguard resources from exotic invasive pests and diseases,� and to monitor and manage existing agricultural pests and diseases in the U.S.3

APHIS�s regulatory authority over biotech products falls under the realm of plant pests.4 Any genetically modified organism is subject to APHIS regulatory authority to the extent it is or is suspected to become a plant pest. Commonly called regulated articles,5 these organisms must get approval from APHIS prior to introduction into the environment (�outside the constraints of physical containment�).6

APHIS�s regulatory authority over genetically modified organisms stems from the Plant Protection Act (PPA) and the Plant Quarantine Act (PQA). The PPA became law in June 2000 as part of the Agricultural Risk Protection Act, and gave APHIS the primary responsibility to determine whether or not a plant or plant product has the potential to become a plant pest. Accordingly, APHIS was given authority to prohibit or restrict the importation, exportation, and the interstate movement of plants, plant products, certain biological control organisms, noxious weeds, and plant pests.7

APHIS has 4 major regulatory procedures regarding genetically modified plants, including notification, permit applications, petition for deregulation, and an extension of a deregulated status. Notification or a permit application is required for the field-testing, importation, and interstate movement of regulated articles. A petition for deregulation and an extension of a deregulated status are required for commercialization.

Notification has become the most common means to field test regulated articles in the past few years. Instituted in 1993, it was established as a simplified and streamlined process to field-test, import, and move genetically modified plants. Originally intended for 6 major crops only (corn, tomato, cotton, soybean, potato, and tobacco), APHIS extended notification to cover most genetically modified plants in 1995. Currently all plants, unless they are pharmaceutical-producing or are considered noxious weeds, can be field-tested for 1 year via approval through APHIS�s streamlined notification process. 8

To introduce a genetically modified plant through the notification system, the plant species must meet the following 6 eligibility criteria: 1) the plant must not be on the federal noxious weed list9 or be considered a noxious weed in the area of introduction, 2) inserted DNA must be stably integrated, 3) function of the inserted DNA must be known and known not lead to plant disease, 4) inserted DNA must not produce an infectious entity, produce substances likely to be toxic to non-target species, or encode products intended for pharmaceutical use, 5) virus-derived sequences must be known noncoding regulatory sequences or unlikely to produce virus virulence and spread in plants, and 6) inserted sequence must not be derived from potential human or animal disease-causing agents.10

Additionally, articles introduced through notification must follow and meet 6 performance standards intended to contain the regulated article and prevent its offspring from persisting in the environment. To meet APHIS performance standards, regulated articles must: 1) be transported and stored in ways that minimize the escape of viable plant parts into the environment, 2) not be mixed with nonregulated plant material, 3) maintain plant and plant part identity, and be contained or devitalized after use, 4) have no pathogenic vector associated with the plant, 5) be field-tested and managed in a way that precludes persistence of the plant and its progeny (meaning it should not be able to reproduce on its own), and 6) must be managed to prevent persistence of the plant or its progeny. 11

To aid institutions in the notification process, APHIS has created an extensive User�s Guide12 that gives sample notification letters and suggestions of information to include. Although APHIS does not require notifications to contain extensive data, they do require all notifications to include a description of the regulated article (including identity of the plant, method of gene transfer, and full description of inserted sequences) field-testing information (geographic details, size, means of transport, and duration), and a signed statement certifying eligibility criteria and performance standards are met.13

Upon receiving a notification letter, APHIS will provide appropriate State regulatory official(s) with a copy of the notification within 5 days. APHIS will notify the applicant of acknowledgement or denial of their request within 10 days of receipt of an interstate movement letter or within 30 days of receipt of an importation or environmental release letter. If introduction by the notification letter is denied, the applicant may apply for a permit.14

Permit applications are required for articles that do not qualify for notification or were denied notification. As with notification, permit applicants are trying to obtain authorization to move, import, or field-test a regulated article. The permit application is more detailed than the notification letter, and its primary purpose is to provide enough information for APHIS to determine if the article will become a plant pest. Information regarding confinement issues is emphasized in the application.

All permit applications must include information on the regulated article, the donor organism, and the vector or vector agent. Date of importation, movement or release, port of importation or site release, and a description of the anticipated or actual expression of the altered genetic material and how that differs from the nonmodified parental organism must also be included.

Additionally, the following information is required in a permit application:

The process for reviewing a permit application is longer than the time allotted for notifications. Permits should be submitted to APHIS 120 days before intended release of the regulated article. APHIS conducts an initial review within 30 days of receiving the application, and may request additional information after an application is submitted. If an application is complete, APHIS notifies the applicant that the 120-day review has begun. APHIS maintains a database on their website that allows applicants to check the status of their permit application.16

APHIS conducts an environmental assessment for the proposed introduction of the regulated article from the permit applications. If a �Finding of No Significant Impact (FONSI) is made, APHIS approves the permit application. If approved, applicants must allow APHIS and state inspectors access to their test trials and submit field trial results within 6 months of field-testing.17

APHIS�s third regulatory procedure, a Petition for Determination of Nonregulated Status, is the sole route for commercialization of a transgenic plant and the major route for commercialization of transgenic plant products. The petition requests APHIS to determine if a particular GM plant should be considered a regulated article, that is, if it should be considered a plant pest. If APHIS grants a petition, it is stating that the regulated article does not pose a significant risk to be or become a plant pest, and therefore does not fall under APHIS�s regulatory authority.

Deregulation petitions include detailed scientific data that APHIS reviews on a case-to-case basis. APHIS uses the information given to determine if the proposed regulated article meets the following criteria: 1) displays no plant pathogenic characteristics, 2) is not more likely to become a weed than its parent organism, 3) is not likely to increase the weediness of cultivated, feral, or wild-related plants, 4) does not damage processed agricultural commodities, and 5) is unlikely to cause unintended harm to other organisms.18 As with notification letters and permit applications, APHIS provides organizations with a sample petition and user�s guide for determination of nonregulatory status.19

APHIS recommends that each petition include the following:

  1. Rational for Development of the Product
  2. Relevant Biology of the Plant (taxonomy, genetics, pollination, evidence of reported weediness, and sexual compatibility with wild and free-living relatives). Virus-resistant plants should include additional information (virus nucleic acid type, type of infection, virus host, how the virus is transmitted�)
  3. Description of the Transformation System (method of DNA transformation)
  4. Donor Genes and Regulatory Sequences
  5. Genetic Analysis and Agronomic Performance
  6. Environmental Consequences of Introduction of the Transformed Cultivar
  7. Adverse Consequences of Introduction20
After APHIS receives a petition, they either approve (in whole or in part) or deny the petition in writing. Applicants of a rejected petition may appeal the decision within 10 days. To date, APHIS has not rejected any petitions.

One particular concern many scientists have about deregulation is that it is absolute. Once APHIS approves a petition to deregulate an article, the agency has no regulatory authority over the transgenic plant or its progeny. They can no longer exercise additional oversight on the plant and its descendants or require monitoring of them.21

APHIS�s 4th regulatory procedure is an extension of determination of nonregulated status. This extension proposes that a currently genetically modified regulated article is similar enough to a previously deregulated article that it does not pose a plant pest risk, and accordingly, should be deregulated itself. The extension request is a streamlined petition that focuses on the differences between the currently regulated article and its substantially similar deregulated counterpart. 22

APHIS also provides a user�s guide for extension requests. In it, APHIS outlines genetic modifications it believes are unlikely to pose new risks beyond those that were considered in the related organism�s deregulation process.23 All petitions should include information on the phenotypic expression of the genetic modifications and any expected differences in phenotype between the currently regulated article and its related deregulated article. Additionally, petitions should include data from at least one field trial.24

EPA

I. Intergeneric Microorganisms

The EPA has regulatory jurisdiction over 2 types of GMOs, both of which are applicable to trees. The first includes genetically modified microorganisms created from genetic material combined from different taxonomic genera. These microorganisms are created to be used commercially as biofertilizers, biosensors, waste treatment or pollutant degradation, or for commodity or specialty chemical production.25 This type of genetic modification (and regulation) applies to genetically modified trees designed for bioremediation. Regulatory authority was given to the EPA under section 5 of the Toxic Substances Control Act (TSCA). The TSCA Biotechnology Program of the Office of Pollution Prevention and Toxics is responsible for regulation.26

Microorganisms subject to regulation under TSCA section 5 are viewed as �new� microorganisms. The EPA believes because they are formed by combining genetic material from organisms classified in different taxonomic genera, i.e., intergeneric, these microorganisms have a higher potential for exhibiting a new trait or combinations of traits. The EPA chose to establish regulation at this level because these new traits were unlikely to occur naturally, and can be viewed as the result of substantial human intervention.27

The TSCA Biotechnology Program has two regulatory procedures regarding intergeneric microorganisms. An MCAN, Microbial Commercial Activity Notice, is required to manufacture, import, or process a living intergeneric microorganism for commercial purposes. MCANs must be filed at least 90 days prior to a microorganism�s commercial manufacture, import, or processing. Currently, the EPA has not developed an MCAN form, although they are considering doing so after they gain additional experience with intergeneric microorganisms.28

The EPA has established requirements though, of what an MCAN notification should include. The following is a brief outline of the required information.

  1. Description of the recipient and new microorganism subject to TSCA. This section must include classification, nomenclature, and identification (the latter is the most significant) of the microorganism. It is up to the submitter to determine the best method to determine and present the organism�s identification. Possibilities include phenotype information or bacteria classification schemes. Additionally, morphological, biochemical, immunological, or physiological characteristics may be used and needed.
  2. Genetic construction of the new microorganism. This part must include taxonomies of subject and donor microorganisms, an illustration of the final construct, methods and sources used to produce the final construct, and properties of the subject microorganism.
  3. Potential human health effects: This section is used to identify the organism�s potential to cause pathogenicity and toxicity in humans. The section must include nature and degree of pathogenicity, virulence, or infectivity in humans, results of pathological tests on effects of the subject microorganism in mammalian species (if applicable), ability to colonize humans, ability to grow at human body temperature, susceptibility to control measures like antibiotics, nature and degree of toxicity to humans, and results of toxicological tests on effects of the subject microorganism or its products in mammalian species (like allergenicity, ingestion, inhalation�)
  4. Phenotypic and ecological characteristics: This section is recommended to include the ability of the subject microorganism to cause or be associated with disease and its ability to survive and spread in the environment. It must include information on the nature and degree of pathogenicity, virulence, or infectivity to mammals, fish, invertebrates, and plants, toxicity of microbially-produced toxins to mammals, fish, invertebrates, and plants, and involvement in or effects on biogeochemical processes by the microorganism.29
  5. Byproducts, total production volume, use information, and consumer exposure: This section must include information on the production volume of microorganisms, potentially hazardous types of byproducts from microbial production, final commercial use of subject microorganism and its products, and likely consumer exposures to subject microorganism and its products.
  6. Worker exposure and environmental release: EPA uses this information to develop a quantitative assessment of potential for release and exposure of the microorganism, and uses it to develop a risk assessment for the microorganism. This section must include a description of the industrial site to produce the organism (including operation description, process description, diagram of operation, occupational exposure and information on environmental release and disposal (info on control technology).30
Submitters are allowed to consolidate MCAN notifications for microorganisms that have the same or similar uses and have similar test data and information. There is a $2500 fee for all MCAN submissions. Additionally, EPA recommends institutions talk with EPA representatives prior to working on the MCAN to determine if additional information may be required.31

Institutions wanting to conduct an individual field test for intergeneric microorganisms are required to complete a TSCA Experimental Release Application (TERA). The TERA is similar to the MCAN in content, but requires less information and time to complete. The application should be submitted 60 days prior to testing (MCAN requires a 90 day review). It should only be submitted by institutions interested in conducting field tests on their products�institutions wanting to commercially manufacture, import, or process their new microorganisms must submit an MCAN.

Below is a brief review of information required in a TERA application.32

  1. Microorganism identity information (same as requirement for MCANs)
  2. Phenotypic and ecological characteristics as they relate to research and development conditions�including habitat and geographical distribution, survival, dissemination, and detection of the subject microorganism, anticipated adverse ecological effects, and involvement in biogeochemical cycling processes)
  3. Detailed description of the proposed research and development activity�including methods of application or release and characteristics of the test site
  4. Information on monitoring, confinement, mitigation, and emergency mitigation procedures. 33
II. PIPs

In addition to intergeneric microorganisms, the EPA also has regulatory authority over plant-incorporated-protectants. These protectants, commonly called PIPs, are pesticidal substances produced and used by living plants. These substances can occur naturally in plants, or they can be introduced into plants via conventional breeding or genetic engineering. When introduced through genetic engineering, PIPs must go through a registration process with the EPA to ensure they meet federal safety requirements. Plants containing pesticidal substances introduced through conventional breeding are exempt from most regulatory requirements. 34

One common example of a PIP is Bacillus thuringensis (Bt) bacteria. Scientists add the Bt gene to a plant�s genetic material, and the plant then produces its own pesticidal substance. The protein and the genetic material, in this case the Bt gene, are under the regulatory authority of the EPA. Regulatory authority was given to the EPA over PIPs through 2 statutes: the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) and the Federal Food Drug and Cosmetic Act (FFDCA). 35

The EPA has regulatory authority over PIPs because they have the broader responsibility of ensuring the safety of biological and chemical pesticides. To meet this responsibility, the EPA regulates the distribution, sale, use, and testing of plants and microbes producing chemical substances. With authority granted by FIFRA, the EPA issues experimental use permits for field-testing and registrations for the commercialization of PIPs as a means to regulate their distribution, sale, use, and testing. Under the FFDCA, the EPA sets tolerance limits for pesticides used on and in food and feed or establishes exemption from the limit through an evaluation process. 36

PIPs go through the same registration process as required of conventional chemical pesticides. There are numerous application forms and notifications to complete before the EPA will allow commercialization. In short, detailed information about the ingredients, a summary of the physical and chemical properties of the pesticide, and its proposed labeling and packaging must be included.37 There is a separate, and shorter, application for experimental use only.38 Upon receipt, all applications for experimental use or registration are announced in the Federal Register. 39

Regulation for PIPs was first established with the 1986 Coordinated Framework. In 1994 the EPA published proposed regulations describing their policies for PIPs (then called plant-pesticides). In 2001, the EPA issued its final ruling of these regulations.40

Notes

  1. McCammon
  2. Vogt, Donna and Mickey Parish. CRS Report to Congress. http://usinfo.state.gov/topical/global/biotech/crsfood.htm#Table%201.%20Overview%20of%20Agency%20Resp
  3. APHIS website, http://www.usda.gov/mrp/, accessed 6/26/02.
  4. APHIS defines plant pests as �any living stage of invertebrates, plants, viruses, or infectious agents which can directly or indirectly injure or cause disease or damage in or to any plants, plant parts, or any processed, manufactured or products of plants.� 7 CRF 340.1, http://www.aphis.usda.gov/ppq/biotech/7cfr340.html#340.1
  5. �Any organism which has been altered or produced through genetic engineering, if the donor organism, recipient organisms, or vector or vector agent belongs to any genus or taxon designated in a list t (7 CFR 340.2) of taxa known to have plant pests, and meets the definition of plant pest, is an unclassified organism, or is believed to be a plant pest.� 7 CRF 340.1, http://www.aphis.usda.gov/ppq/biotech/7cfr340.html#340.1
  6. NRC. Environmental Effects of Transgenic Plants; The Scope and Adequacy of Regulation. NAP 2001
  7. Questions and Answers about the Plant Protection Act. September 2000. http://www.ceris.purdue.edu/napis/a-facts/qappact.html Accessed 6/26/02.
  8. NRC. Environmental Effects of Transgenic Plants; The Scope and Adequacy of Regulation. NAP 2001
  9. http://www.aphis.usda.gov/ppq/permits/fnwsbycat-e.PDF
  10. A General Introduction to Notification, http://www.aphis.usda.gov/ppq/biotech/notgen.html, accessed 6/27/02
  11. NRC, Environmental Effects of Transgenic Plants; The Scope and Adequacy of Regulation. NAP 2001
  12. http://www.aphis.usda.gov/ppq/biotech/usergdn.html
  13. For further detail see http://www.aphis.usda.gov/ppq/biotech/notgen.html#comments
  14. http://www.aphis.usda.gov/ppq/biotech/notgen.html
  15. For a copy of the permit application see http://199.132.50.50/Oxygen_FOD/FB_MD_PPQ.nsf/d259f66c6afbd45e852568a90027bcad/d39deb77403d6909852568f200633402?OpenDocument
  16. http://www.aphis.usda.gov/ppq/biotech/status.html
  17. NRC, Environmental Effects of Transgenic Plants; The Scope and Adequacy of Regulation. NAP 2001
  18. Ibid.
  19. http://www.aphis.usda.gov/ppq/biotech/user.html#rationale
  20. Ibid.
  21. NRC, Environmental Effects of Transgenic Plants; The Scope and Adequacy of Regulation. NAP 2001
  22. Ibid.
  23. http://www.aphis.usda.gov/ppq/biotech/gaddbeg.htm
  24. NRC, Environmental Effects of Transgenic Plants; The Scope and Adequacy of Regulation. NAP 2001
  25. Information Systems for Biotechnology. Virginia Tech. http://www.isb.vt.edu/greenhouse/green_man.section2.htm#foot7 Accessed July 1, 2002.
  26. http://www.aphis.usda.gov/biotech/OECD/usregs.htm
  27. http://www.epa.gov/biotech_rule/pdf/c006.pdf
  28. http://www.epa.gov/opptintr/biotech/pdf/ptcbio.pdf
  29. For a complete listing of information required in this section see http://www.epa.gov/opptintr/biotech/pdf/ptcbio.pdf.
  30. http://www.epa.gov/opptintr/biotech/pdf/ptcbio.pdf
  31. Ibid.
  32. Ibid.
  33. http://www.epa.gov/opptintr/biotech/pdf/ptcbio.pdf
  34. http://www.epa.gov/oscpmont/qanda.pdf
  35. http://www.epa.gov/oppbppd1/biopesticides/what_are_biopesticides.htm
  36. McCammon, Sally. Regulating the Products of Biotechnology. http://usinfo.state.gov/journals/ites/1099/ijee/bio-mccammon-2.htm Accessed 6/02
  37. see http://www.epa.gov/opprd001/registrationkit/index.htm
  38. see http://www.epa.gov/opprd001/forms/8570-17.pdf
  39. Personal email. Phil Hutton, Chief of Microbial Pesticides Branch, EPA. 6/19/02.
  40. see http://www.epa.gov/pesticides/biopesticides/pip/pip_rule.pdf for a copy of the final ruling

� 2002 Lara Vallely

Hosted by www.Geocities.ws

1